Role of ghrelin in growth hormone-deficient patients

References

• Tannenbaum GS, Ling N. The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology115(5), 1952–1957 (1984).
   PubMed Web of Science ®Google Scholar
• Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology114(5), 1537–1545 (1984).
   PubMed Web of Science ®Google Scholar
• Howard AD, Feighner SD, Cully DF et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science273(5277), 974–977 (1996).
   PubMed Web of Science ®Google Scholar
• Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab.87(6), 2988 (2002).
   PubMed Web of Science ®Google Scholar
• Papotti M, Ghe C, Cassoni P et al. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab.85(10), 3803–3807 (2000).
   PubMed Web of Science ®Google Scholar
• Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature402(6762), 656–660 (1999).
   PubMed Web of Science ®Google Scholar
• Dall R, Kanaley J, Hansen TK et al. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. Eur. J. Endocrinol.147(1), 65–70 (2002).
   PubMed Web of Science ®Google Scholar
• Espelund U, Hansen TK, Hojlund K et al. Fasting unmasks a strong inverse association between ghrelin and cortisol in serum: studies in obese and normal-weight subjects. J. Clin. Endocrinol. Metab.90(2), 741–746 (2005).
   PubMed Web of Science ®Google Scholar
• Lucidi P, Murdolo G, Di Loreto C et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes51(10), 2911–2914 (2002).
   PubMed Web of Science ®Google Scholar
• Arvat E, Maccario M, Di Vito L et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab.86(3), 1169–1174 (2001).
   PubMed Web of Science ®Google Scholar
• Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab.85(12), 4908–4911 (2000).
   PubMed Web of Science ®Google Scholar
• Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes50(8), 1714–1719 (2001).
   PubMed Web of Science ®Google Scholar
• Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature409(6817), 194–198 (2001).
   PubMed Web of Science ®Google Scholar
• Druce MR, Wren AM, Park AJ et al. Ghrelin increases food intake in obese as well as lean subjects. Int. J. Obes. Relat. Metab. Disord.29(9), 1130–1136 (2005).
   PubMed Web of Science ®Google Scholar
• Neary NM, Small CJ, Wren AM et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab.89(6), 2832–2836 (2004).
   PubMed Web of Science ®Google Scholar
• Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab.86(12), 5992–5995 (2001).
   PubMed Web of Science ®Google Scholar
• Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature407(6806), 908–913 (2000).
   PubMed Web of Science ®Google Scholar
• Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J. Clin. Endocrinol. Metab.88(2), 701–704 (2003).
   PubMed Web of Science ®Google Scholar
• Broglio F, Arvat E, Benso A et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab.86(10), 5083–5086 (2001).
   PubMed Web of Science ®Google Scholar
• Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther.22(9), 847–853 (2005).
   PubMed Web of Science ®Google Scholar
• Dornonville de la Cour C, Lindstrom E, Norlen P, Hakanson R. Ghrelin stimulates gastric emptying but is without effect on acid secretion and gastric endocrine cells. Regul. Pept.120(1–3), 23–32 (2004).
   PubMedGoogle Scholar
• Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun.280(3), 904–907 (2001).
   PubMed Web of Science ®Google Scholar
• Masuda Y, Tanaka T, Inomata N et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun.276(3), 905–908 (2000).
   PubMed Web of Science ®Google Scholar
• Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes50(4), 707–709 (2001).
   PubMed Web of Science ®Google Scholar
• Otto B, Cuntz U, Fruehauf E et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol.145(5), 669–673 (2001).
   PubMed Web of Science ®Google Scholar
• Van der Lely AJ, Tschop M, Heiman ML et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrinol. Rev.25(3), 426–457 (2004).
   PubMed Web of Science ®Google Scholar
• Kojima M, Kangawa K. Ghrelin: structure and function. Physiol. Rev.85(2), 495–522 (2005).
   PubMed Web of Science ®Google Scholar
• Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol.159(6), 1029–1037 (2002).
   PubMed Web of Science ®Google Scholar
• Camina JP. Cell biology of the ghrelin receptor. J. Neuroendocrinol.18(1), 65–76 (2006).
   PubMed Web of Science ®Google Scholar
• Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin – a hormone with multiple functions. Front Neuroendocrinol.25(1), 27–68 (2004).
   PubMed Web of Science ®Google Scholar
• Smith RG, Van der Ploeg LH, Howard AD et al. Peptidomimetic regulation of growth hormone secretion. Endocrinol. Rev.18(5), 621–645 (1997).
   PubMed Web of Science ®Google Scholar
• Murata M, Okimura Y, Iida K et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem.277(7), 5667–5674 (2002).
   PubMed Web of Science ®Google Scholar
• Tschop M, Flora DB, Mayer JP, Heiman ML. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes. Res.10(10), 991–999 (2002).
   PubMedGoogle Scholar
• Thorner MO, Strasburger CJ, Wu Z et al. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH. J. Clin. Endocrinol. Metab.84(6), 2098–2103 (1999).
   PubMed Web of Science ®Google Scholar
• Trainer PJ, Drake WM, Katznelson L et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Engl. J. Med.342(16), 1171–1177 (2000).
   PubMed Web of Science ®Google Scholar
• Muller AF, Lamberts SW, Janssen JA et al. Ghrelin drives GH secretion during fasting in man. Eur. J. Endocrinol.146(2), 203–207 (2002).
   PubMed Web of Science ®Google Scholar
• Groschl M, Uhr M, Kraus T. Evaluation of the comparability of commercial ghrelin assays. Clin. Chem.50(2), 457–458 (2004).
   PubMed Web of Science ®Google Scholar
• Janssen JA, van der Toorn FM, Hofland LJ et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur. J. Endocrinol.145(6), 711–716 (2001).
   PubMed Web of Science ®Google Scholar
• Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med.346(21), 1623–1630 (2002).
   PubMed Web of Science ®Google Scholar
• Hansen TK, Dall R, Hosoda H et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin. Endocrinol. (Oxford)56(2), 203–206 (2002).
   PubMed Web of Science ®Google Scholar
• Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JP. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin. Endocrinol. (Oxford)60(1), 137–141 (2004).
   PubMed Web of Science ®Google Scholar
• Giavoli C, Cappiello V, Corbetta S et al. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults. Clin. Endocrinol. (Oxford)61(1), 81–87 (2004).
   PubMed Web of Science ®Google Scholar
• Eden Engström B, Burman P, Holdstock C, Karlsson FA. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J. Clin. Endocrinol. Metab.88(11), 5193–5198 (2003).
   PubMed Web of Science ®Google Scholar
• Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur. J. Endocrinol.153(4), 545–549 (2005).
   PubMed Web of Science ®Google Scholar
• Svensson J, Monson JP, Vetter T et al. Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency. Clin. Endocrinol. (Oxford)58(5), 572–580 (2003).
   PubMed Web of Science ®Google Scholar
• Codner E, Cassorla F, Tiulpakov AN et al. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. Clin. Pharmacol. Ther.70(1), 91–98 (2001).
   PubMed Web of Science ®Google Scholar
• Chapman IM, Pescovitz OH, Murphy G et al. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults. J. Clin. Endocrinol. Metab.82(10), 3455–3463 (1997).
   PubMed Web of Science ®Google Scholar
• Mericq V, Cassorla F, Bowers CY, Avila A, Gonen B, Merriam GR. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. J. Pediatr. Endocrinol. Metab.16(7), 981–985 (2003).
   PubMed Web of Science ®Google Scholar
• Aimaretti G, Baffoni C, Broglio F et al. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency. Clin. Endocrinol. (Oxford)56(6), 765–771 (2002).
   PubMed Web of Science ®Google Scholar
• Gauna C, Meyler FM, Janssen JA et al. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J. Clin. Endocrinol. Metab.89(10), 5035–5042 (2004).
   PubMed Web of Science ®Google Scholar
• Janssen JA, Poldermans D, Hofland LJ et al. There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J. Endocrinol. Invest.27(7), 659–664 (2004).
   PubMed Web of Science ®Google Scholar
• Briefel RR, McDowell MA, Alaimo K et al. Total energy intake of the US population: the third National Health and Nutrition Examination Survey, 1988–1991. Am. J. Clin. Nutr.62(5 Suppl.), 1072S–1080S (1995).
   Web of Science ®Google Scholar
• Zadik Z, Chalew SA, McCarter RJ Jr, Meistas M, Kowarski AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab.60(3), 513–516 (1985).
   PubMed Web of Science ®Google Scholar
• Rigamonti AE, Pincelli AI, Corra B et al. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J. Endocrinol.175(1), R1–R5 (2002).
   Google Scholar
• Broglio F, Benso A, Castiglioni C et al. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J. Clin. Endocrinol. Metab.88(4), 1537–1542 (2003).
   PubMed Web of Science ®Google Scholar
• Chapman IM, Bach MA, Van Cauter E et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J. Clin. Endocrinol. Metab.81(12), 4249–4257 (1996).
   PubMed Web of Science ®Google Scholar
• Bach MA, Rockwood K, Zetterberg C et al. The effects of MK-0677, an oral growth hormone secretagogue, in patients with hip fracture. J. Am. Geriatr. Soc.52(4), 516–523 (2004).
   PubMed Web of Science ®Google Scholar
• Shiiya T, Nakazato M, Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab.87(1), 240–244 (2002).
   PubMed Web of Science ®Google Scholar
• Lindeman JH, Pijl H, Van Dielen FM, Lentjes EG, Van Leuven C, Kooistra T. Ghrelin and the hyposomatotropism of obesity. Obes. Res.10(11), 1161–1166 (2002).
   PubMedGoogle Scholar
• Svensson J, Lonn L, Jansson JO et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab.83(2), 362–369 (1998).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Itoh T, Murakami S et al. Treatment of cachexia with ghrelin in patients with COPD. Chest128(3), 1187–1193 (2005).
   PubMed Web of Science ®Google Scholar
• Akamizu T, Takaya K, Irako T et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur. J. Endocrinol.150(4), 447–455 (2004).
   PubMed Web of Science ®Google Scholar
• Enomoto M, Nagaya N, Uematsu M et al. Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans. Clin. Sci. (London)105(4), 431–435 (2003).
   PubMed Web of Science ®Google Scholar
• Bowers CY, Alster DK, Frentz JM. The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J. Clin. Endocrinol. Metab.74(2), 292–298 (1992).
   PubMed Web of Science ®Google Scholar
• Laron Z, Bowers CY, Hirsch D et al. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinol. (Copenhagen)129(5), 424–426 (1993).
   PubMedGoogle Scholar
• Bellone J, Ghizzoni L, Aimaretti G et al. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. Eur. J. Endocrinol.133(4), 425–429 (1995).
   PubMed Web of Science ®Google Scholar
• Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR. Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. J. Clin. Endocrinol. Metab.80(5), 1681–1684 (1995).
   PubMed Web of Science ®Google Scholar
• Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature. J. Clin. Endocrinol. Metab.80(10), 2987–2992 (1995).
   PubMed Web of Science ®Google Scholar
• Copinschi G, Van Onderbergen A, L’Hermite-Baleriaux M et al. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J. Clin. Endocrinol. Metab.81(8), 2776–2782 (1996).
   PubMed Web of Science ®Google Scholar
• Koutkia P, Schurgin S, Berry J et al. Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women. Am. J. Physiol. Endocrinol. Metab.289(5), E814–E822 (2005).
   PubMed Web of Science ®Google Scholar
• Choi K, Roh SG, Hong YH, et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology144(3), 754–759 (2003).
   PubMed Web of Science ®Google Scholar
• Kim SW, Her SJ, Park SJ et al. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone37(3), 359–369 (2005).
   PubMed Web of Science ®Google Scholar
• Patel AD, Stanley SA, Murphy KG et al. Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul. Pept.134(1), 17–22 (2005).
   PubMedGoogle Scholar
• Barazzoni R, Bosutti A, Stebel M et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab.288(1), E228–E235 (2005).
   PubMed Web of Science ®Google Scholar
• Nakagawa E, Nagaya N, Okumura H et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin. Sci. (London)103(3), 325–328 (2002).
   PubMed Web of Science ®Google Scholar
• McCowen KC, Maykel JA, Bistrian BR, Ling PR. Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents. J. Endocrinol.175(2), R7–R11 (2002).
   PubMed Web of Science ®Google Scholar
• Leonetti F, Iacobellis G, Ribaudo MC et al. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity. Regul. Pept.122(3), 179–183 (2004).
   PubMedGoogle Scholar
• Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J. Endocrinol. Invest.25(11), RC36–RC38 (2002).
   PubMed Web of Science ®Google Scholar
• Murdolo G, Lucidi P, Di Loreto C et al. Insulin is required for prandial ghrelin suppression in humans. Diabetes52(12), 2923–2927 (2003).
   PubMed Web of Science ®Google Scholar
• Saad MF, Bernaba B, Hwu CM et al. Insulin regulates plasma ghrelin concentration. J. Clin. Endocrinol. Metab.87(8), 3997–4000 (2002).
   PubMed Web of Science ®Google Scholar
• Flanagan DE, Evans ML, Monsod TP et al. The influence of insulin on circulating ghrelin. Am. J. Physiol. Endocrinol. Metab.284(2), E313–E316 (2003).
   PubMed Web of Science ®Google Scholar
• Rosenfalck AM, Maghsoudi S, Fisker S et al. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J. Clin. Endocrinol. Metab.85(11), 4173–4181 (2000).
   PubMed Web of Science ®Google Scholar
• Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab.83(2), 379–381 (1998).
   PubMed Web of Science ®Google Scholar
• Muccioli G, Ghe C, Ghigo MC et al. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol.157(1), 99–106 (1998).
   PubMed Web of Science ®Google Scholar
• Cheng K, Chan WW, Barreto A Jr, Convey EM, Smith RG. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3´,5´-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology124(6), 2791–2798 (1989).
   PubMed Web of Science ®Google Scholar
• Popovic V, Pekic S, Micic D et al. Evaluation of the reproducibility of the GHRH plus GHRP-6 test of growth hormone reserve in adults. Clin. Endocrinol. (Oxford)60(2), 185–191 (2004).
   PubMed Web of Science ®Google Scholar
• Popovic V, Leal A, Micic D et al. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet356(9236), 1137–1142 (2000).
   PubMed Web of Science ®Google Scholar
• Andersen M, Hansen TB, Stoving RK et al. The pyridostigmine-growth-hormone-releasing-hormone test in adults. The reference interval and a comparison with the insulin tolerance test. Endocrinol. Metab.3(3), 197–206 (1996).
   Google Scholar
• Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med.334(5), 292–295 (1996).
   PubMed Web of Science ®Google Scholar
• Broglio F, Gianotti L, Destefanis S et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin. Endocrinol. (Oxford)60(5), 592–599 (2004).
   PubMed Web of Science ®Google Scholar
• Nagaya N, Moriya J, Yasumura Y et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation110(24), 3674–3679 (2004).
   PubMed Web of Science ®Google Scholar